2009

Дек
26

Подпишись на RSS-трансляцию статей.

Для того чтобы вовремя узнавать о новых статьях и публикациях в моем журнале, вы можете подписаться на RSS-трансляцию и всегда быть в курсе обновлений, при этом значительно сэкономив время. Что такое RSS и как его использовать, читайте далее…
Jxnj.1 Подпишись на RSS трансляцию статей.

Автор nyse    Рубрики Блог
2009

Апр
15

Торговая стратегия торговли на NYSE,NASDAQ,AMEX (Черновик, постоянно буду дописывать)

В процессе редактирования 21.10.2010 Суть моей торговой стратегии проста,  это торговля на продолжение тренда или разворот акции внутри дня после значительного роста или падения.

Основные сигналы на продолжение тренда:

  • На дневном графике акция должна расти или пройти  ключевой уровень. Чаще всего торгую акции которые находятся на годовом хае или прошли какой то значимый уровень за 100 дней.
  • Смотрю уровни на дневном и 15 минутном масштабе, там должен быть виден четкий тренд
Автор admin    Рубрики Стратегия
2014

Сен
16

SPY консолидируется на премаркете

Ближайший уровень поддержки по SPY – 198.65 уровень сопротивления – 198.90

 analytics 16 09 2014 SPY консолидируется на премаркете

AVNR продажа ниже 12

CAB покупка на продолжение тренда вверх

YY покупка при удержании 80

WDAY покупка выше 86

UBNT покупка выше 43

 

Gapping up/down: SODA +4% on M&A related news, VNET +4%, AEO +2% and DATA +2% on upgrades/initiations; ALOG -3.5% after earnings, Casino names trading lower, ACI -2% after dg

Gapping up
In reaction to strong earnings/guidance: SINO +33.1%, (surged higher into the close after reporting earnings in late trade), FONR +9.2%, AXR +3.5%

M&A news: SODA +4.2% (in discussions with British fund regarding sale, according to reports)

Other news: RWLK +5.9% (cont momentum following IPO), PSTI +5.9% (pursues development strategy in Japan where new law accelerates path to market), SSH +5.5% (to provide clinical updates from the North American feasibility study), UEC +5% (reports positive preliminary economic assessment on Anderson Project in Arizona), OREX +3.9% (after seeing notable late move off lows on insider buy disclosures), AXAS +2.3% (raises Q3 production guidance to 6.9-7.0 Boepd, up from 6.5-6.7 Boepd), JDSU +1.9% (favorable commentary on Monday’s Mad Money), CSIQ +1.1% (announces 1.5 MW solar module supply agreement in Jordan), YNDX +1.1% (modest rebound after yesterday’s decline)

Analyst comments: DRYS +5.2% (initiated with a Buy at Deutsche Bank), VNET +4.4% (upgraded to Outperform from Sector Perform at Pacific Crest), STRI +4.1% (upgraded to Buy at Craig Hallum), GASS +3.5% (initiated with a Buy at Deutsche Bank), AEO +2% (upgraded to Overweight from Equal Weight at a boutique firm), DATA +1.8% (upgraded to Outperform from Neutral at Credit Suisse), DSX +1.4% (initiated with a Buy at Deutsche Bank), TNK +1.3% (initiated with a Buy at Deutsche Bank), TAP +1.3% (initiated with an Outperform at Cowen), CPLP +1% (initiated with a Buy at Deutsche Bank), TEX +0.9% (upgraded to Buy at Stifel)

Gapping down
In reaction to disappointing earnings/guidance: COOL -13.7%, (thinly traded), FULL -4.7%, ALOG -3.5%, PARN -2.5%

M&A news: AT -18.9% (provides update on outcome of strategic review process; sale or merger of co not in best interests of co or its stakeholders at this time), BUD -1.6% (WSJ says Anheuser-Busch InBev seeking financing for SABMiller plc (SBMRY) deal), ORAN -1.4% (Group will launch a friendly voluntary cash tender offer for the acquisition of 100% of the capital of Jazztel)

Select EU heavy-weight names showing weakness: ALU -1.5%, AZN -1.4%, BCS -1.1%, ARMH -0.8%, DB -0.7%, LYG -0.6%

Select Casino stocks trading lower: MGM -3%, LVS -2.4%, WYNN -1.8%, CNTY -1.5%, BYD -0.9%

Other news: SIGA -27.1% (files for Chapter 11 reorganization), PIP -15.9% (still checking), OPXA -10.2% (announces proposed public offering of common stock), OXPA -10.2% (still checking), GST -7.9% (announced that it intends to offer 17 mln shares of its common stock ), AVNR -6.7% (modest pull back following yesterdays 80%+ advance), CHA -3.2% (Shanghai -1.8% overnight), CHL -2.9% (Shanghai -1.8% overnight), ACI -2.1% (China plans to ban low grade coal, according to reports), NFLX -1.8% (FCC to consider net neutrality for mobile broadband, according to reports), BTU -1.2% (China plans to ban low grade coal, according to reports), GPRO -1.1% (cont pre-mkt vol), AA -1% (announces proposed public offering of 25 mln depository share of Mandatory Convertible Preferred Stock)

Analyst comments: ACI -2.1% (downgraded to Reduce from Neutral at Nomura), CMI -1.2% (downgraded to Market Perform from Outperform at Wells Fargo), BTU -1.2% (downgraded to Reduce from Neutral at Nomura), SAP -1.1% (initiated with a Sector Perform at RBC Capital Mkts), YOKU -0.8% (hearing cautious OTR mention), OXY -0.6% (downgraded to Equal Weight from Overweight at Barclays), ADBE -0.6% (assumed with a Sector Perform (down from Outperform) at RBC Capital Mkts)

 

Автор GT_support    Рубрики Торговые идеи
2014

Сен
15

Снижение тарифов на торговом терминале Takion

Компания GT Capital Group рада сообщить вам о снижении тарифов для новых трейдеров на торговом терминале Takion. Так же сумма минимального депозита составляет всего 500$. Мы надеемся, что новые условия сделают для вас доступнее  фондовый рынок США.

Ознакомиться с новыми тарифами

В ближайшие недели у нас будет еще несколько нововведений которые должны порадовать трейдеров. 

Стоимость торгового терминала Takion может быть уменьшена по согласованию с менеджером.

Автор nyse    Рубрики Блог
2014

Сен
15

SPY отыграл гэп вниз на премаркете

Ближайший уровень поддержки по SPY – 198.60 уровень сопротивления – 199.10

 analytics 15 09 2014 SPY отыграл гэп вниз на премаркете

AVB покупка от 145

SLG покупка выше 104

VNG смотрим на покупку

 

Gapping up/down: TWGP +12% on M&A approval, spirit related names also higher on M&A spec in the space, NOK +2% on upgrade; TEX -8% after guidance, RAX -4% after dg

Gapping up
M&A news: TWGP +11.7% (ACP Re announced that ACP Re has received all regulatory approvals required in connection with its previously announced acquisition of Tower), CTSH +2.8% (to acquire TriZetto for $2.7 bln in cash), WHR +2.1% (receives written approval from the China Securities Regulatory Commission to acquire a 51% stake in Hefei Rongshida Sanyo Electric), VC +1.1% (may be a possible takeover target, Bloomberg real M&A column says)

Other news: RSH +17.6% (considering $585 mln financing package, also Hearing Suntrust analyst suggesting reasoning behind potential Amazon (AMZN) deal), OTIV +13.2% (extending last weeks gains), TAP +7.2% (in response to M&A stories in the space), HALO +5.9% (partner Baxter (BAX) receives FDA approval from HYQVIA for treatment of adults with primary immunodeficiency), AU +5.5% (Hearing speculation that company will not proceed with restructuring), BPOP +3.8% (positive Barrons mention), ATHM +3.6% (favorable commentary on Friday’s Mad Money, Tiger Global Management discloses 18.5% passive stake), BUD +3.1% (in financing talks for SABMiller deal), MYL +2.5% (Mylan Labs signs agreement with Gilead (GILD) to accelerate access to hepatitis C treatments), BITA +2.5% (Tiger Global Management discloses 14.9% passive stake), TGTX +2.5% (announces special protocol assessment agreement with the FDA for its first phase 3 clinical trial of TG-1101), DEO +2.2% (in response to M&A stories in the space), TASR +2% (Columbus and Knoxville join major cities moving to AXON cameras and EVIDENCE.com; new body-worn camera programs launch in Argentina and United Arab Emirates), YHOO +1.8% (Alibaba (BABA) may increase IPO range amid high demand to above $70 from $60-66 prior, according to reports), MO +1.8% (co has a 26.9% voting interest in Sabmiller (SBMRY))

Analyst comments: WGO +5.2% (initiated with an Outperform at BMO Capital Mkts), PAY +1.8% (initiated with a Buy at Monness Crespi & Hardt), NOK +1.7% (upgraded to Outperform at Oppenheimer), AYI +1.6% (upgraded to Buy from Neutral at Goldman), ABX +0.9% (upgraded to Neutral from Underweight at HSBC Securities)

Gapping down
In reaction to disappointing earnings/guidance: TEX -7.8%

Select oil/gas related names showing early weakness: E -1.2%, SDRL -1%, TOT -1%, BP -0.7%

Other news: NPSP -14.0% (FDA Advisory Committee votes 8-5 the recommend approval of Natpara), NETE -7% (pulling back following Friday’s advance), ACHN -3% (still checking), INSY -2.9% (disclosed it received a subpoena requesting documents regarding Subsys), ALXN -1.8% (reports 5 yr results of Asfotase Alfa in ped patients with severe HPP), WB -1.5% (still checking), BHP -0.8% (weak industrial production figures out of China), DE -0.6% (in sympathy with TEX), CAT -0.5% (in sympathy with TEX)

Analyst comments: RAX -3.9% (downgraded to Neutral from Overweight at JP Morgan), TSLA -2.2% (weakness attributed to Morgan Stanley analyst comments, suggesting stock may be a bit ahead of itself), PKD -1.6% (downgraded to Equal Weight from Overweight at a boutique firm), PLOW -1.2% (downgraded to Neutral from Outperform at Robert W. Baird), UBS -1.2% (downgraded to Equal Weight from Overweight at Barclays), TRP -1% (downgraded to Sell from Neutral at Goldman), CLW -0.7% (downgraded to Neutral at DA Davidson)

Автор GT_support    Рубрики Торговые идеи
2014

Сен
12

SPY слегка снижается

Ближайший уровень поддержки по SPY – 200.00 уровень сопротивления – 200.40

 analytics 12 09 2014 SPY слегка снижается

LULU проада от 44

LE продажа ниже 45

WB продажа от 25

VSI продажа от 44

DATA продажа от 76.50

VNET покупка от 16

 

Gapping up/down: ULTA +16% and DRI +3.5% after earnings, CNVR +32% after merger with ADS +2.4%, NFLX +0.7% after upgrade; CHKE -8% after earnings

Gapping up
In reaction to strong earnings/guidance: ULTA +16.1%, CGA +8.3%, SPWH +7.6%, CVTI +7.6%, DRI +3.5%, NTWK +3%

M&A news: CNVR +32.6% (Alliance Data to acquire Conversant), ADS +2.4%

Other news: ASTI +11.5% (regains compliance with NASDAQ minimum bid price rule), STRI +11.5% (still checking), XPO +8.7% (announced a $700 mln investment by PSP Investments, GIC, Singapore’s sovereign wealth fund, and Ontario Teachers’ Pension Plan; co also raised its FY17 financial targets), LXRX +8.4% (announced a publication in the American Diabetes Association’s Journal), ACAD +4.8% (favorable commentary on Thursday’s Mad Money), FUEL +4.4% (following late spike into the close), HTZ +4.2% (Hertz Global reaches an agreement-in-principle with Carl Icahn to add Three Directors), VNET +4% (cont volatility), RMTI +3.9% (still checking), CRTO +3.7% (following late move higher), BTX +3.7% (co’s subsidiary reached an agreement with Cancer Research UK and Cancer Research Technology for a clinical trial of immunotherapy vaccine for lung cancer), TASR +2.9% (favorable commentary on Thursday’s Mad Money), ISIS +2.7% (favorable commentary on Thursday’s Mad Money), SCOK +2.5% (following 18% move higher yesterday), OREX +2.3% (mentioned positive on CNBC’s Fast Money), NVO +2.1% ( FDA’s Endocrinologic and Metabolic Drugs Advisory Committee votes 14-1 in favor of recommending approval of liraglutide for chronic weight management ), BCS +2.1% (John McFarlane appointed to succeed Sir David Walker as Chairman), WWAV +1.8% (cont M&A spec), TNET +1.6% (prices 12 mln shares of common stock at a price of $25.50 per share ), S +1.5% (announces exclusive new rate plan for iPhone 6 and iPhone 6 plus and a revolutionary new way to acquire iPhone, also upgraded to Outperform from Mkt Perform at Cowen), FEYE +1.1% (cont volatility), HDS +1% (announces sale of 20,000,000 shares of common stock by selling stockholders)

Analyst comments: NLNK +4.9% (initiated with a Buy at Mizuho), TMUS +1% (upgraded to Buy from Hold at Argus), IRC +0.9% (upgraded to Buy from Hold at KeyBanc Capital Mkts), NFLX +0.7% (upgraded to Equal Weight from Underweight at Barclays)

Gapping down
In reaction to disappointing earnings/guidance: CHKE -7.9%

Select metals/mining stocks trading lower: GFI -2.5%, HMY -1.1%, GOLD -1%, IAG -0.5%.

Other news: ACHN -3.3% (negative commentary on Thursday’s Mad Money), HCN -3.1% (announces proposed offering of 15,500,000 shares of common stock), SDRL -2.8% (still checking), PPL -1.9% (Federal Appeals Court sides with PPL, affirms New Jersey Court decision invalidating state legislation subsidizing new power plants), AMAT -1.4% (unfavorable China’s Ministry of Commerce determination in Tokyo Electron deal), KATE -1.1% (negative commentary on Thursday’s Mad Money)

Analyst comments: RKUS -4.5% (initiated with a Underweight at Morgan Stanley), DDR -3.5% (downgraded to Hold from Buy at KeyBanc Capital Mkts, downgraded to Neutral from Buy at UBS)

Автор GT_support    Рубрики Торговые идеи
2014

Сен
11

SPY падает на премаркете

Ближайший уровень поддержки по SPY – 199.00 уровень сопротивления – 199.70

 analytics 11 09 2014 SPY падает на премаркете

LE продажа от 40

EMES покупка выше 130

SLCA покупка выше 70

UTHR продажа от 122

GPRO покупка выше 69

 

Gapping up/down: JDSU +14% after guidance/spin-off announcement, LULU +14% after earnings, GPRO +3% after gt raise; RH -4% after earnings, energy and metals tradind lower, CROX -3% after dg

Gapping up
In reaction to strong earnings/guidance: GRO +19.4%, JDSU +14%, (reaffirms; to Separate into Two Industry-Leading Public Companies), LULU +13.6%, SIGM +10%, LFVN +8%, WTSL +5.9%, MBUU +5.1%, BRC +3.1%, RSH +2.2%

M&A news: RAX +0.9% (cont M&A spec)

Other news: IMRS +19.7% (neurosurgical HFD rocker arm receives FDA clearance), DGLY +12.8% (to introduce ‘Bullet Camera’ option for FirstVU HD body camera system at IACP conference), LAND +7.7% (announces REIT Election), GOGO +5.4% (Gogo and T-Mobile (TMUS) to deliver free in-flight texting and voicemail to T-Mobile customers), RXII +4.5% (presented an update on the company’s dermatology and ophthalmology franchises), PT +3.8% (still checking), FNSR +3.6% (following JDSU news/guidance), GPRO +3.3% (favorable commentary on Wednesday’s Mad Money), SOL +2.1% (to supply 10MW DCR solar modules to Utility-Scale project in India), POWR +1.9% (disclosed it acquired the electrical contracting business of Apex Controls), MDVN +1.4% (FDA approves new indication for the use of XTANDI (enzalutamide) capsules for patients with metastatic castration-resistant prostate cancer), MBLY +1.4% (still checking), EXXI +1.2% (Energy XXI late spike attributed to speculation of Gulf of Mexico asset sale), GTAT +1.2% (modestly rebounding), EMC +1.2% (reports of VMW stake sale), TWX +0.9% (does not have plans for HBO spin off, ‘seriously’ looked at Fox (FOXA) offer, CEO said, according to reports)

Analyst comments: GPRO +3.3% (target raised to $70 from $42 at Citigroup), NES +2% (initiated with a Buy at Stifel), SEAS +1.5% (upgraded to Outperform from Neutral at Macquarie), PBR +1.3% (initiated with an Outperform at Cowen), TS +0.9% (upgraded to Overweight from Equal-Weight at Morgan Stanley), TCAP +0.7% (upgraded to Outperform from Market Perform at Wells Fargo), JLL +0.6% (upgraded to Overweight from Neutral at JP Morgan), GDP +0.6% (initiated with an Outperform at Cowen)

Gapping down
In reaction to disappointing earnings/guidance: EOPN -28.6%, (updates guidance; announces that three customers will not be renewing contracts; names new head of sales organization ), SYMX -22.9%, DLIA -13%, FIVE -5%, RH -3.8%

Select China related names showing weakness: CAAS -8.8%, CSUN -4.7%, CGA -4.5%, MY -4.5%, VIPS -2%

Select metals/mining stocks trading lower: HMY -2.6%, MT -1.4%, SLV -1.2%, FCX -1.2%, SLW -1.1%, GOLD -0.9%, GG -0.8%, ABX -0.7%

Select oil/gas related names showing early weakness: E -2.4%, RIG -1.6%, BHP -1.6%, SSL -1.6%, STO -1.3%, TOT -1.2%

Other news: INVE -17.4% (announces proposed stock offering ), ASTM -4.4% (announces pricing of public offering of 13,725,490 shares of Common Stock at $2.55/share), NETE -3.7% (following 100%+ move higher yesterday). NBR -3.6% (hearing Activist investor may be selling shares, according to article), TEF -1.9% (still checking), TWTR -1.6% (announces $650 mln convertible unsecured senior note offering; announces amendment to revolving credit agreement)

Analyst comments: CROX -3.7% (downgraded to Neutral from Buy at Buckingham Research), M -1.8% (downgraded to Neutral from Buy at Sterne Agee)

Автор GT_support    Рубрики Торговые идеи
2014

Сен
10

SPY топчется на месте

Ближайший уровень поддержки по SPY – 199.25 уровень сопротивления – 199.75

 analytics 10 09 2014 SPY топчется на месте

THC продажа ниже 61

BITA покупка при удержании  82

NPSP продажа от 30

 

Gapping up/down: PANW +5% after earnings, CLF +2% on amended credit facility, TWTR +3% after upgrade; KKD -5% after earnings, AU -12% on restructuring announcement, GTAT -6% on dg at GS

Gapping up
In reaction to strong earnings/guidance: MNDL +10.2%, LMNR +8.1%, DIOD +6.8%, PANW +5.3%, LE +5%, UNIS +4.6%, PPHM +3.2%, PDLI +3.1%, SIRI +1.1%, IHT +1%, SAIC +0.5%.

M&A news: IMPV +2.8% (Imperva, TIBX, TDC among possible takeover targets by HP (HPQ), according to reports), EXPR +1.2% (Barron’s mentions name as M&A target), FDO +0.3% (Dollar General (DG) commences cash tender offer to acquire FDO at $80 per share).

Select EU bell weather names showing strength: BP +1.7%, ING +1.2%, DB +0.9%, RDS.A +0.9%, ALU +0.6%.

Select Biotech stocks trading higher: MNOV +13.3%, NPSP +13% (following FDA briefing docs), TKMR +3.2%, SPPI +2.4%, ACHN +1%.

Other news: DRL +12.4% (announces the sale of ~$430 mln in assets), PVCT +7.5% (still checking), BDBD +6.8% (favorable commentary on Tuesday’s Mad Money), SUPN +6.2% (Orchard Hill Capital Management files amended 13D; request that the Board hires a strategic advisor to consider selling the Company), BWEN +4.1% (announced $14 million in new tower orders from a U.S. wind turbine manufacturer), RADA +3.9% (cont momentum), SUNE +3.6% (Google (GOOG) executes $145 million investment in SunEdison and TerraForm Power’s (TERP) largest solar plant in North America), GPRO +3% (still checking), CLF +1.8% (amended revolving credit facility to allow for $200 mln share repurchase program), FEYE +1.5% (in sympathy with PANW earnings), LTM +1.2% (favorable commentary on Tuesday’s Mad Money), TFSL +1.1% (authorizes the purchase of up to 10,000,000 shares of the Company’s outstanding common stock), THOR +1.1% (announced start of Heartmate III U.S. clinical trial) CRM +1% (signs agreement to establish new european data centre in France; selects Interxion (INXN) as service provider), HAIN +1% (favorable commentary on Tuesday’s Mad Money), TSL +1% (to supply 70MW high efficiency modules to a large-scale solar power project in Chile), KFRC +1% (announces increase to board share buyback authorization by $70 mln).

Analyst comments: TWTR +2.7% (upgraded to Buy from Neutral at UBS), LB +0.9% (upgraded to Outperform from Neutral at Credit Suisse), COH +0.8% (upgraded to Overweight from Neutral at Atlantic Equities), TPLM +0.8% (upgraded to Buy from Accumulate at KLR Group)

Gapping down
In reaction to disappointing earnings/guidance: MGCD -9.7%, KKD -5.2%, URBN -2%, (Thus far during the third quarter of fiscal 2015, comparable Retail segment net sales are low single-digit negative), CBSO -1.8%, CRDS -1.7%, MANU -0.7%.

Other news: AU -11.9% (to explore the possibility of restructuring co into simpler and more focused entities), RSH -10.6% (cont weakness following Wedbush target cut to $0), AHH -5.7% (announces public offering of 5 mln shares of common stock), WBAI -5.4% (Muddy waters follow up from Value Walk), ACT -2.8% ( negative vote from the FDA’s Cardiovascular and Renal Drugs Advisory Committee regarding NDA for nebivolol/valsartan for the treatment of hypertension), SCOK -2.8% (modestly pulling back after yesterday’s advance), AVB -2.4% (announces offering of 4.5 mln shares of common stock), GFI -1.8% (may be in sympathy with AU), EQY -1.6% (announced 3.825 mln share public offering of common stock), STM -1.5% (potentially related to Apple (AAPL) event), TI -1.4% (América Movil (AMX) and Telefonica (TEF) among cos that are close to bid for Telecom Italia’s (TI) Brazil operations, according to reports), ARMH -1.1% (potentially related to Apple (AAPL) event).

Analyst comments: GTAT -6.4% (downgraded to Neutral from Buy at Goldman), BYD -3.4% (downgraded to Equal-Weight from Overweight at Morgan Stanley), MBLY -2.8% (downgraded to Hold from Buy at Deutsche Bank on valuation), EBAY -1.3% (downgraded to Neutral from Overweight at Piper Jaffray), SAVE -1.2% (downgraded to Mkt Perform from Outperform at Cowen), TIF -0.8% (downgraded to Neutral from Outperform at Credit Suisse), AAPL -0.6% (downgraded to Sector Perform from Outperform at Pacific Crest).

Автор GT_support    Рубрики Торговые идеи
2014

Сен
9

iPhone 6 и iPhone 6 Plus

iPhone 6 %D0%B8 iPhone 6 Plus  iPhone 6 и iPhone 6 Plus

 Apple представила две модели iPhone. Но осталось место и для приятных неожиданностей.

 

Автор nyse    Рубрики Статьи
2014

Сен
9

SPY понизился на премаркете

Ближайший уровень поддержки по SPY – 200.25 уровень сопротивления – 200.90

 analytics 09 09 2014 SPY понизился на премаркете

CMGE продажа от 28.50

MSI продажа от 61

 

Gapping up/down: BURL +6% and CASY +4% after earnings/guidance, BNNY and IPAS +37% on M&A news, BNNY peers trading higher, MZOR +7% on CFDA approval, THLD +15% on initiation; FRAN -12%, TITN -11%, and FCEL -10% after earnings, POT -1% after dg

Gapping up
In reaction to strong earnings/guidance: BURL +6.1%, CASY +4.1%, TPLM +3.4%, KFY +3%, HELI +2.2%, HDS +1.9%, CTLT +1.1%.

M&A news:BNNY +37.4% (to be acquired by General Mills (GIS) for $46 per share in cash), IPAS +36.8% (to explore strategic alternatives), GFIG +7.2% (BGC Partners (BGCP) announces intent to commence all cash tender offer to acquire GFI Group Shares for $5.25 Per Share).

Select BNNY peers showing strength: WWAV +5.5%, BDBD +4.5%, HAIN +3.8%.

Select Mad Money mentions trading higher: ATK +2%, NFLX +1.6%, LMT +1.1%, RTN +0.9%, SKX +0.5%.

Other news: MZOR +6.8% (receives China CFDA approval for its Renaissance Systems), IDTI +4.8% (working closely with Intel (INTC) on the development of wireless charging solutions), NVFY +3.8% (announces purchase order fulfilled with IKEA China), STKL +3.6% (will further expand its Modesto, California aseptic processing and packaging operation), GTAT +3.1% (ahead of Apple’s product event — speculation as supplier), HSOL +2.6% (signs its second supply agreement with Baotou Shansheng New Energy for delivery of 50 MW of HSOL’s PV modules), PRTS +2.2% (named Michael Yoshida Interim Chief Financial Officer; co has initiated a search for a new CFO), ABB +2.1% (announces $4 bln share repurchase), SGMS +1.9% (awarded three-year instant game contract extension with Colorado lottery), ADXS +1.5% (announces completion of an End-of-Phase 2 Meeting with the FDA for its lead Lm-LLO cancer immunotherapy), GLYC +1.1% (announced that data from preclinical studies demonstrating the in vivo efficacy of GMI-1051 will be presented), IMMR +1% (following late move higher on increased volume), MITK +1% (announced that it has agreed to end all pending litigation with Top Image Systems (TISA) andTIS America), JCP +1% (subsidiary commences underwritten public offering of $350 mln aggregate principal amount of senior unsecured notes), LPCN +0.9% (announces first patient dosed in Phase 1 study in pregnant women of LPCN 1107, potentially the first oral product for the prevention of preterm birth), AAPL +0.7% (trading higher in advance of product event).

Analyst comments: THLD +15% (initiated with a Buy at Cantor Fitzgerald), CTIC +9.7% (initiated with a Overweight at Piper Jaffray), ECYT +5.5% (initiated with a Buy at Cantor Fitzgerald), CEMP +4.2% (receives $10 mln milestone payment from Toyama Chemical Co), MACK +3.5% (initiated with a Buy at Cantor Fitzgerald ), MBLY +3.4% (hearing positive Morgan Stanley comments as catalyst), SYF +3.2% (initiated with a Overweight at JP Morgan and Morgan Stanley, among others), GCA +2.8% (upgraded to Buy at Stifel following MGAM purchase), LYG +2.3% (upgraded to Overweight from Neutral at HSBC Securities), MT +1.9% (upgraded to Outperform from Neutral at Credit Suisse), VRTU +1.7% (upgraded to Overweight from Neutral at JP Morgan), BCS +1.6% (upgraded to Overweight from Neutral at HSBC Securities), MDVN +1.4% (upgraded to Outperform from Mkt Perform at Bernstein), AMRI +1.3% (initiated with a Overweight at JP Morgan), DHI +1.2% (upgraded to Overweight from Neutral at JP Morgan)

Gapping down
In reaction to disappointing earnings/guidance: FRAN -11.7%, TITN -10.7%, FCEL -10.5%, PBY -7.1%, CNSI -5%, FUEL -2.4%, (announces CFO transition and reaffirms prior guidance for the 3Q14 and FY14 ), PTN -1%.

Other news: RADA -5.5% (following 130%+ surge higher following intraday earnings release), AVP -4.1% (announced resignation of CFO Kimberly Ross; Robert Loughran appointed acting CFO effective October 2, 2014), PF -3.7% (announced secondary offering of 15 mln shares of common stock by selling shareholders), DOC -2.6% (announced public offering of 9 mln shares of common stock; announces over $300 mln of commitments for new unsecured revolving credit facility), BKD -1.7% (prices public offering of 8,955,223 shares of Common Stock at $33.50/share), TNET -1.3% (announced commencement of secondary public offering of 10,500,000 shares by stockholders), AKS -1.3% (still checking), WBAI -0.9% (late weakness on cautious Muddy Waters mention).

Analyst comments: LUV -1.1% (initiated with a Neutral at Credit Suisse), POT -1% (downgraded to Underperform from Mkt Perform at Cowen), MOS -0.8% (downgraded to Sector Perform from Outperform at RBC Capital Mkts), JBLU -0.7% (initiated with a Underperform at Credit Suisse), CVX -0.7% (downgraded to Underperform from Neutral at BofA/Merrill).

Автор GT_support    Рубрики Торговые идеи
2014

Сен
8

SPY на премаркете стоит в узком коридоре после гэпа вниз

Ближайший уровень поддержки по SPY – 200.80 уровень сопротивления – 201.00

 analytics 08 09 2014 SPY на премаркете стоит в узком коридоре после гэпа вниз

DATA смотрим на продажу ниже 70

SPLK продажа ниже 59.50

NKE смотрим на продолжение роста

COST смотрим на покупку выше 127

NXPI покупка выше 71

 

Gapping up/down: MGAM +28% following merger with GCA, RAX +5% on M&A reports, FEYE +3% after upgrade; CPB -3% after earnings, UK stocks under pressure, F-2% after dg

Gapping up
In reaction to strong earnings/guidance: XCRA +2.1%

M&A news: MGAM +28.7% (to be acquired by Global Cash Access (GCA) for $36.50/share in cash), RAX +4.7% (CenturyLink (CTL) considering acquisition of RAX, according to reports)

Other news: MSTX +11.1% (announces positive top line results from Phase 2 study of AIR001), ISNS +7.3% (co and NuPark LLC announced that they have completed an integration and partnership agreement), ASTI +6.8% (files for 1 mln share common stock offering by selling shareholders), ALLT +5.1% (receives an expansion order of $15 mln from a Tier-1 Operator), HTZ +3.3% (announces Mark Frissora to step down as Chairman and CEO), BCRX +3.1% (announces RAPIVAB trial results for the treatment of influenza), YHOO +2.9% (rising in advance of BABA IPO release, also positive commentary on Mad Money), GLUU +2.7% (discloses it extended its licensing agreement with Kim Kardashian by three years), HIMX +1.9% (Google Glass on sale in GOOG Play store), NVAX +1.7% (presents data on RSV F Nanoparticle vaccine induced monoclonal antibody), GTAT +1.1% (Former GTAT employee Paul Matthews claims that GTAT sapphire covers are in AAPL iPhone 6, according to reports), SYN +1.1% (highlights SYN-005 data; SYN-005 neutralizing antibody combination protects against pertussis in murine and non-human primate models)

Analyst comments: INFN +4.6% (upgraded to Buy from Hold at Jefferies), FEYE +3.2% (upgraded to Buy from Neutral at UBS), MTRX +2.2% (upgraded to Buy from Hold at KeyBanc Capital Mkts), SGI +1.9% (upgraded to Buy at DA Davidson; tgt raised to $12), BAC +0.9% (upgraded to Buy from Neutral at Goldman), UBNT +0.9% (initiated with an Outperform at FBN Securities), TSLA +0.7% (initiated with an Outperform at FBN Securities), AIG +0.6% (initiated with a Buy at Citigroup)

Gapping down
In reaction to disappointing earnings/guidance: CPB -3.2%.

Select UK listed names showing weakness following sell-off in FTSE: LYG -4.7%, RBS -4.3%, GSK -3.7%, BCS -3.5%, AZN -2.4%, RDS.A -1.9%, HSBC -1.9%, BP -1.8%, SHPG -1.6%, RIO -1.5%, ING -1.3%

Other news: WRLD -7.7% (disclosed KPMG would not respond to recent request for proposal to serve as independent registered public accounting firm), DGLY -5.9% (cont volatility), AKS -3.4% (announces concurrent offerings of 35 mln shares common stock and senior unsecured notes with aggregate value of $430 mln), XON -2.9% (files mixed securities shelf offering), UEC -2.2% (files shelf offering for ~1.86 mln shares of common stock ), TKMR -1.7% (negative mention on Mad Money)

Analyst comments: KERX -6% (downgraded to Underperform at FBR Capital ), F -2.5% (downgraded to Underweight at Morgan Stanley), HMY -2.5% (initiated with a Neutral at JP Morgan), GOLD -1.6% (initiated with a Neutral at JP Morgan)

Автор GT_support    Рубрики Торговые идеи
2014

Сен
5

SPY упал на премаркете

Ближайший уровень поддержки по SPY – 199.50 уровень сопротивления – 200.30

 analytics 05 09 2014 SPY упал на премаркете

COST покупка при ужержании 125

EMES покупка выше 125

EGN смотрим на разворот

 

Gapping up/down: BLOX +13% and AMBA +9% after earnings, PRAN +28% after orphan designation status, CIEN +2% after upgrade; GPX -6% and FNSR -5% after earnings/SSS, KORS -5% after offering

Gapping up
In reaction to strong earnings/guidance: BLOX +13.4%, AMBA +9.3%, LOCO +2.9%, VRNT +2.6%.

Other news: PRAN +27.6% (received orphan designation status for its product for the treatment of Huntington’s disease), HART +13.7% (received orphan designation status for its inBreath airway transplant system to restore the structure and/or function of the trachea subsequent to tracheal damage due to cancer, injury or infection), NSPH +10.8% (has engaged Jefferies LLC as its financial advisor to assist it in the development and evaluation of a full range of potential strategic alternatives for the Company), TASR +6% (higher following announcement that the NYPD will begin a pilot program of equipping officers with body cameras), OMED +4.1% (FDA removes partial clinical hold on OncoMed’s ipafricept), ICLD +2.8% (announces multi-site deployment of security and threat prevention solutions and services for a large global consulting firm), MOBI +2.6% (announces repurchase of 16 mln shares from Sequoia Capital ), GPRO +1.7% (up in sympathy following supplier AMBA earnings), DGLY +1.5% (cont usual volatility pre-mkt), JOY +1% (positive Barron’s mention), SD +0.8% ( announces $200 mln share repurchase program)

Analyst comments: IPCI +3.7% (upgraded to Buy at Maxim Group), VRTX +2.3% (upgraded to Buy from Neutral at Goldman), CIEN +1.8% (upgraded to Buy from Neutral at Goldman), ICPT +1.8% (initiated with an Outperform at Cowen), MTRX +1.7% (upgraded to Overweight from Equal Weight at First Analysis Sec), SNDK +1.5% (upgraded to Overweight from Equal-Weight at Morgan Stanley), BLUE +1.4% (initiated with a Buy at Sun Trust Rbsn Humphrey), INSM +1.4% (initiated with an Outperform at Cowen), MBLY +1.4% (target raised to $52 at RBC Capital Mkts), IL +1.1% (upgraded to Buy at Stifel ), ING +1% (upgraded to Overweight from Equal Weight at Barclays), BEAV +1% (upgraded to Buy from Hold at Deutsche Bank), BP +0.9% (upgraded to Buy from Neutral at Citigroup), QGEN +0.6% (upgraded to Buy from Sell at DZ Bank)

Gapping down
In reaction to disappointing earnings/guidance: ZQK -12.4%, GPS -5.8%, ZUMZ -5.1%, FNSR -5%, SEAC -4.3%, BEBE -2.8%, BEBE -2.8%, COO -2.1%.

Other news: REPH -40.5% (announced that the Phase 2b clinical trial of Dex-IN for the treatmnet of acute post-operative pain is not expected to reach statistical significance at its current design), KORS -5.1% (Michael Kors files for ordinary share shelf offering by selling shareholders; launches secondary public offering of ordinary shares on behalf of Sportswear, one of its principal founding shareholders, for the offering of 11,629,627 ordinary shares), TUMI -4.4% (announced secondary offering of 8 mln shares of common stock by Doughty Hanson & Co. Managers Limited), PNNT -4% ( announces public offering of 11 mln shares of common stock), GLNG -3.5% (announces secondary offering of ~27.83 mln shares of its common stock by World Shipholding Ltd.), HMY -2.5% (still checking), ST -2.2% (announced offering of ~15.05 mln ordinary shares by selling shareholders), CX -2% (prices of €400 mln and $1.1 bln in Senior Secured Notes), SDRL -1.7% (still checking), AU -1.6% (still checking), GSK -1.5% (will not be able to fill all demand for flu vaccines, according to reports), GTAT -1.3% (cont vol due to speculation surrounding iPhone component), SHPG -1% (still checking).

Analyst comments: TTWO -1.3% (downgraded to Neutral from Buy at Sterne Agee), CS -1.1% (downgraded to Neutral from Buy at UBS), PCLN -0.7% (downgraded to Equal Weight from Overweight at Evercore ), MS -0.7% (downgraded to Neutral from Outperform at Macquarie).

Автор GT_support    Рубрики Торговые идеи

Чтобы первыми узнавать последние новости советуем вам подписаться на RSS. Если вы используете стандартные rss клиенты, можете кликнуть по ссылками ниже и читать новости в них, либо получать обновления на почту или твиттер:

Следуйте за мной на Twitter! Чат трейдеров в SKYPE!

Лучшие посты месяца

Свежие комментарии

Самое интересное

Партнеры

Облако тегов

Группа Вконтакте

Меню: